Toxicity Monitoring on Phase III Trials with Administrative Data

Karin L Gaensler

Efficacy and Safety of Novel CD80 IL15 IL15Ra Expressing Autologous AML Vaccines

Leukaemia

Hematology and hematologic malignancies

Thomas J Kipps

Chronic Lymphocytic Leukemia Research Consortium

Leukaemia

Hematology and hematologic malignancies

Targeting BCL6 in Tyrosine Kinase-Driven Leukemia

Leukaemia

Hematology and hematologic malignancies

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Leukaemia

Hematology and hematologic malignancies

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Pediatric oncology or childhood cancer Hematology and hematologic malignancies

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies

Jeffrey S Miller

NK Cells, their Receptors and Unrelated Donor Transplant

Leukaemia

Hematology and hematologic malignancies

Peter C Adamson

COG NCTN Network Group Operations Center

Leukaemia

Pediatric oncology or childhood cancer

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Leukaemia

Hematology and hematologic malignancies